Skip to content
Sustiva

Sustiva

Efavirenz

Efavirenz tablets for HIV-1 infection. They stop the virus from replicating by blocking its reverse transcriptase enzyme.

All strengths and pack prices
StrengthPackPricePer unit
200mg10 tablets$88.00$8.80
200mg20 tablets$165.00$8.25
200mg30 tablets$236.00$7.87
200mg60 tablets$417.00$6.95
200mg90 tablets$578.00$6.42
200mg120 tablets$726.00$6.05
200mg180 tablets$1022.00$5.68
200mg270 tablets$1484.00$5.50
200mg360 tablets$1913.00$5.31
600mg10 tablets$106.00$10.60
600mg20 tablets$206.00$10.30
600mg30 tablets$290.00$9.67
600mg60 tablets$526.00$8.77
600mg90 tablets$745.00$8.28
600mg120 tablets$937.00$7.81
600mg180 tablets$1320.00$7.33
600mg270 tablets$1851.00$6.86
600mg360 tablets$2297.00$6.38
Active ingredient
Efavirenz
Route
Oral use
Form
Tablet
Strengths
200mg · 600mg

This listing uses Sustiva as a reference name. A generic equivalent is supplied; its exact brand and manufacturer are confirmed before supply.

Sustiva details

Alternative names
efavirenz
Therapeutic class
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Pharmacological class
NNRTI
Contraindications
concurrent use of highly CYP3A4-dependent medications; severe hepatic impairment
Minor side effects
dizziness; headache; insomnia
Moderate side effects
vivid dreams; rash; fatigue
Dosage forms
Tablet
Administration route
Oral use
Originator
Bristol-Myers Squibb
Onset time
2–4 weeks
Duration
24 hours
Storage instructions
Store below 25°C.
Drug interactions
Rifampin; Simvastatin; St. John's Wort
Age restrictions
Approved for children over three months and adults.
Serious side effects

severe depression and suicidal ideation, requires immediate medical attention; severe hepatotoxicity, requires immediate medical attention

Patient summary

Efavirenz tablets for HIV-1 infection. They stop the virus from replicating by blocking its reverse transcriptase enzyme.

Mechanism of action

Non-competitively inhibits HIV-1 reverse transcriptase, halting viral replication inside host cells.

Pregnancy and breastfeeding

Pregnancy: Potential risk of neural tube defects. Avoid in first trimester. Breastfeeding: Not recommended.

What you will receive

Sustiva is used here as a reference originator brand name to identify the medicine. We are not affiliated with the brand owner, and this listing does not offer the originator product.

  • The supplied product is a generic equivalent containing Efavirenz, not the originator brand shown as the reference.
  • The exact generic brand, manufacturer and dispatch location are confirmed based on the product, destination and available manufacturer or partner warehouse.
  • Check the final product details at checkout before confirming an order.

How we compare medicine brands and generics